Oral route supportive care measures during high dose methotrexate (drug) administration in children with blood cancer.
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C859- Non-Hodgkin lymphoma, unspecifiedHealth Condition 3: C858- Other specified types of non-Hodgkin lymphoma
- Registration Number
- CTRI/2022/02/040229
- Lead Sponsor
- Dr Aditya Kumar Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Established diagnosis of hematolymphoid malignancy (acute lymphoblastic leukemia, Non-Hodgkin lymphoma) - primary or relapsed disease
On chemotherapy protocol requiring high dose methotrexate (HDMTX) (>=1g/m2/dose)
Eligible for HDMTX administration as per unit protocol and chemotherapy protocol
Atleast one previous course of HDMTX uneventfully administered with intravenous alkaline hydration.
Prior to start of HDMTX:
MTX toxicity during previous courses of HDMTX.
Requirement of intravenous hydration or intravenous alkalinization for any other reason (e.g. concurrent chemotherapy requiring intravenous hydration)
After the MTXT1:
Unsafe MTXT1
Clinical features of MTX toxicity
Nausea - Grade 3 and above
Vomiting - Grade 3 and above
Oral mucositis - Any grade
Fever - temperature > 100.4 F
Contraindication to enteral feeds e.g. ileus
Withdrawal criteria (after enrolment):
Failure to place NG tube due to patient denial or uncooperative child when IARTa is <40% or IARTb is <40% or IARTc is <85% or IARTd is <85%.
Unsafe MTXT2
Nausea - Grade 3 and above
Vomiting - Grade 3 and above
Oral mucositis - Any grade
Fever - temperature > 100.4 F
Contraindication to enteral feeds e.g. ileus, neutropenic enterocolitis
Requirement of more than 2 bolus doses of oral sodium bicarbonate to maintain target urine pH of 7.0 â?? 8.0
Urine output measured from time point p to time point c is <2ml/kg/hr.
Failed repeat oral dose of sodium bicarbonate or leucovorin 20 minutes after a vomited dose.
More than 2 episodes of vomited oral sodium bicarbonate or leucovorin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method